Target intelligence / Profile preview

FACT complex subunit SPT16 (SUPT16H)

Target
SUPT16H
Molecular classification
Chromatin remodeling factor, Histone chaperone, Transcription elongation factor, Other
01

Overview

FACT complex subunit SPT16 (SUPT16H) is the large subunit of the FACT (Facilitates Chromatin Transcription) complex, an evolutionarily conserved histone chaperone involved in reorganizing nucleosomes to permit access for transcription, DNA replication, and DNA repair machinery[1][2][3]. SUPT16H binds to histones H2A/H2B and H3/H4, mediating nucleosome disassembly during RNA polymerase II transcription elongation and then restoring chromatin structure post-transcription[1][2][3]. Loss-of-function variants in SUPT16H are associated with severe developmental disorders, including neurodevelopmental delay, intellectual disability, and epilepsy[3]. The gene is expressed ubiquitously and is essential for cell growth and survival[3]. No clinically approved drugs specifically target SUPT16H, and it is not currently known to be used as a biomarker or for therapeutic targeting, though its pivotal cellular functions make it an emerging point of interest in chromatin regulation research[1][2][3][4].

Other names
SPT16 homolog, facilitates chromatin remodeling subunitFACT complex subunit SPT16FACT140FACTP140hSPT16FACTSPT16/CDC68FLJ14010FLJ10857CDC68Chromatin-specific transcription elongation factor 140 kDa subunitFacilitates chromatin transcription complex subunit SPT16Facilitates chromatin remodeling 140 kDa subunitNEDDFACSPT16suppressor of Ty 16 homolog
02

Biological functions

Chromatin remodelingRegulation of transcription elongationDNA replicationDNA repairNucleosome disassembly and reassemblyRNA bindingHistone bindingCell survivalCell growth
03

Disease associations

Neurodevelopmental disorder (with dysmorphic facies and thin corpus callosum)Global developmental delayIntellectual disabilityEpilepsyCongenital brain malformation14q11.2 microduplication/deletion syndromeCancer (implicated in cancer biology, but not a classical oncogene)
04

Safety considerations

Essential for cell viability; loss-of-function is lethal in model organisms[3]Mutations may result in global developmental delay or severe neurodevelopmental phenotypes[3]

Beyond the preview

Go deeper on FACT complex subunit SPT16 (SUPT16H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FACT complex subunit SPT16 (SUPT16H).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call